Mucopolysaccharidosis III-B

Rare Disease·MeSH: Rare Diseases

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Mucopolysaccharidosis III-B?

There are 1 clinical trial targeting Mucopolysaccharidosis III-B tracked by BioSniper.

What is the prevalence of Mucopolysaccharidosis III-B?

The estimated prevalence of Mucopolysaccharidosis III-B is approximately 5.0 per 100,000 population.

Deep-dive into Mucopolysaccharidosis III-B

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Mucopolysaccharidosis III-B — Drugs in Development & Clinical Trials | BioSniper